Immunex Announces Date of First Quarter 2001 Earnings Release and Conference Call

Apr 02, 2001, 01:00 ET from Immunex Corporation

    SEATTLE, April 2 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX) will
 release first quarter 2001 earnings on Wednesday, April 18, 2001, after the
 close of U.S. financial markets.  This announcement will be made available on
 the Immunex website at http://www.immunex.com, and on PRNewswire's website at
 http://www.prnewswire.com.
     Additionally, Immunex executives will host a conference call and live
 audio webcast at 2:00 p.m. PDT (5:00 p.m. EDT) on April 18th to discuss the
 company's financial results.  The live webcast can be accessed on the Immunex
 website at http://www.immunex.com/investor_fs3.html.  Replay of the live
 webcast will also be made available on the Immunex website by clicking
 "Investor Relations/Events/Webcasts" shortly after the conclusion of the call
 and will be available through April 25, 2001.
     Immunex Corporation is a leading biopharmaceutical company dedicated to
 improving lives through immune system science innovations.
 
     NOTE:  Except for the historical information contained herein, this news
 release contains forward-looking statements that involve substantial risks and
 uncertainties.  Among the factors that could cause actual results or timelines
 to differ materially are risks associated with research and clinical
 development, regulatory approvals, our supply capabilities and reliance on
 third-party manufacturers, product commercialization, competition, litigation
 and other risk factors listed from time to time in reports filed by Immunex
 with the SEC, including but not limited to risks described under the caption
 "Important Factors That May Affect Our Business, Our Results of Operations
 and Our Stock Price" within our most recently filed Form 10-K.  The
 forward-looking statements contained in this news release represent our
 judgment as of the date of this release.  Immunex undertakes no obligation
 to publicly update any forward-looking statements.
 
 

SOURCE Immunex Corporation
    SEATTLE, April 2 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX) will
 release first quarter 2001 earnings on Wednesday, April 18, 2001, after the
 close of U.S. financial markets.  This announcement will be made available on
 the Immunex website at http://www.immunex.com, and on PRNewswire's website at
 http://www.prnewswire.com.
     Additionally, Immunex executives will host a conference call and live
 audio webcast at 2:00 p.m. PDT (5:00 p.m. EDT) on April 18th to discuss the
 company's financial results.  The live webcast can be accessed on the Immunex
 website at http://www.immunex.com/investor_fs3.html.  Replay of the live
 webcast will also be made available on the Immunex website by clicking
 "Investor Relations/Events/Webcasts" shortly after the conclusion of the call
 and will be available through April 25, 2001.
     Immunex Corporation is a leading biopharmaceutical company dedicated to
 improving lives through immune system science innovations.
 
     NOTE:  Except for the historical information contained herein, this news
 release contains forward-looking statements that involve substantial risks and
 uncertainties.  Among the factors that could cause actual results or timelines
 to differ materially are risks associated with research and clinical
 development, regulatory approvals, our supply capabilities and reliance on
 third-party manufacturers, product commercialization, competition, litigation
 and other risk factors listed from time to time in reports filed by Immunex
 with the SEC, including but not limited to risks described under the caption
 "Important Factors That May Affect Our Business, Our Results of Operations
 and Our Stock Price" within our most recently filed Form 10-K.  The
 forward-looking statements contained in this news release represent our
 judgment as of the date of this release.  Immunex undertakes no obligation
 to publicly update any forward-looking statements.
 
 SOURCE  Immunex Corporation